Drug intelligence / Profile preview

oxybuprocaine

Development stage
Phase 4
Lead developer
Santen Pharmaceutical
Modality
Small Molecules
Administration
Ophthalmic, Topical
01

Overview

Oxybuprocaine is an ester-type local anesthetic primarily used in ophthalmology and otolaryngology to numb the surface of the eye or mucous membranes for short-term medical procedures, such as tonometry, minor operations, removal of foreign bodies from the eye, and diagnostic procedures in ENT. It acts by binding to sodium channels on neuronal membranes, reversibly stabilizing them and decreasing their permeability to sodium ions. This inhibits depolarization and blocks initiation and conduction of nerve impulses. The onset of anesthesia occurs within 30–50 seconds and lasts about 10–30 minutes depending on perfusion. Oxybuprocaine is metabolized by plasma cholinesterases and liver esterases[1][4][5][8].

Brand names
AltafluorFluressMinims Oxybuprocaine
Other names
oxybuprocaine hydrochloridebenoxinateBenox
02

Targets

SCN10A (Sodium channel protein type X alpha subunit)

Beyond the preview

Go deeper on oxybuprocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxybuprocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call